COROPRES 25 mg TABLETS

Introduction

Package Leaflet: Information for the User

Coropres 25mg Tablets

Carvedilol

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

• Keep this package leaflet, as you may need to read it again.
• If you have any questions, consult your doctor or pharmacist.
• This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

1. What Coropres 25 mg tablets are and what they are used for.
2. What you need to know before taking Coropres 25 mg tablets.
3. How to take Coropres 25 mg tablets.
4. Possible side effects.
5. Storage of Coropres 25 mg tablets.
6. Package contents and additional information.

1. What Coropres 25 mg tablets are and what they are used for.

Coropres contains carvedilol as the active ingredient. It belongs to a group of medications known as alpha and beta receptor blockers. Coropres has antioxidant, antihypertensive (reducing blood pressure), vasodilatory, and antianginal properties. Additionally, it reduces cardiac output and has favorable effects on blood circulation at the heart level.

Coropres is indicated for the treatment of:

• Symptomatic congestive heart failure (the heart has lost some of its ability to pump blood) of moderate to severe origin, either ischemic or non-ischemic.
• Essential hypertension (high blood pressure).

• Ischemic heart disease (the heart receives little blood and oxygen).

2. What you need to know before taking Coropres 25 mg tablets.

Do not take Coropres 25 mg tablets if you have:

• Allergy to carvedilol or any of the excipients (listed in section 6).
• A type of decompensated heart failure known as class IV (the heart is unable to perform its pumping function during physical activity and at rest).
• Chronic obstructive pulmonary disease (COPD) with obstructed bronchi (difficulty breathing).
• If your liver is not functioning properly.
• Bronchial asthma.
• A heart condition consisting of second and third degree atrioventricular (A-V) block (unless a permanent pacemaker has been implanted).
• If your heart beats slowly (less than 50 beats per minute).
• Heart failure (or shock, a state in which the heart has been so damaged that it is unable to supply enough blood to the body's organs).
• A heart condition consisting of sinoatrial node block.
• Very low blood pressure (systolic pressure less than 85 mmHg).

Warnings and precautions

Consult your doctor or pharmacist before starting to take Coropres 25 mg tablets.

Inform your doctor if you have any of the following diseases:

• If you have any lung disease.
• If you are diabetic.
• If you have a heart condition.
• If you are taking other medications for heart conditions, especially if you are taking any of the following medications, you should inform your doctor: digitalis (increases the strength of the heartbeat), diuretics (increases urine production), ACE inhibitors (antihypertensive medication), calcium antagonists (antihypertensive medication), and antiarrhythmics (affect heart rhythm).
• If you have any thyroid problems.
• If you are allergic and receiving treatment for your allergy.
• If you have circulation problems or Raynaud's phenomenon.
• If you are scheduled for surgery, inform your doctor that you are being treated with carvedilol.
• If you have a disease called pheochromocytoma.
• If you have psoriasis (skin disease).
• If you have Prinzmetal's angina (chest pain that starts during rest without obvious causes).
• If you are going to undergo an operation with anesthesia. You should inform the anesthesiologist.
• If you use contact lenses. Coropres can reduce tear production.
• If you have severe adverse skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome).

As with all medications with beta-blocking activity, treatment with Coropres should not be stopped abruptly. The dose should be gradually reduced according to your doctor's instructions.

Use in athletes

This medication contains carvedilol, which may produce a positive result in doping tests.

Children and adolescents

Coropres is not recommended for use in children and adolescents under 18 years of age due to insufficient safety and efficacy data.

Taking Coropres with other medications

Inform your doctor or pharmacist if you are using, have recently used, or may need to use any other medication.

This is very important, as taking several medications at the same time can increase or decrease their effect. Therefore, you should not take Coropres with any other medication unless your doctor has allowed it.

Keep in mind that these instructions may also apply to medications that have been used before or may be used after.

It is essential that you inform your doctor if you are taking or have recently taken any of the following medications:

• Fluoxetine and paroxetine (medications for depression).
• Cyclosporine and tacrolimus (medications used to prevent rejection in transplants).
• Digoxin, verapamil, diltiazem, and antiarrhythmic medications (medications used to treat heart problems and high blood pressure).
• Amiodarone (medication used to treat certain heart problems).
• Certain pain relievers of the aspirin and ibuprofen type (NSAIDs).
• Other medications for high blood pressure, barbiturates, phenothiazines, tricyclic antidepressants, vasodilators, and alcohol.
• Medications for diabetes (including insulin and oral antidiabetics).
• Clonidine (medication used to control high blood pressure or migraines).
• Rifampicin (medication used to treat infections).
• Cimetidine (medication used to treat stomach problems).
• Inducers or inhibitors of hepatic metabolism (medications that modify the elimination of other medications from the body).
• Monoamine oxidase inhibitors (medications for depression).
• Beta-agonist bronchodilators (medications used to improve respiratory capacity, such as in asthma).
• Adrenaline/epinephrine (used to treat severe allergic reactions).

Taking Coropres 25 mg tablets with food, drinks, and alcohol

You should avoid taking Coropres at the same time or immediately after taking grapefruit or grapefruit juice. Grapefruit or grapefruit juice can lead to an increase in the active ingredient carvedilol in the blood and cause unpredictable side effects. You should also avoid excessive and simultaneous or occasional consumption of alcohol, as alcohol influences the effect of Coropres.

Your doctor or pharmacist will inform you about the meals with which you should take the medication.

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor before using this medication.

The use of Coropres is not recommended during pregnancy and breastfeeding.

Coropres can cause fetal death in the womb, as well as premature births. Additionally, adverse effects can occur in the fetus and newborn. After birth, the newborn has a higher risk of suffering heart and lung problems.

Coropres passes into breast milk, so its use is not recommended during breastfeeding.

Driving and using machines

Occasionally, Coropres can impair your ability to drive or operate machines. This occurs especially when starting or changing treatment and when taken in combination with alcohol.

Coropres 25 mg tablets contain sucrose and lactose

If your doctor has told you that you have an intolerance to certain sugars, consult with them before taking this medication.

3. How to take Coropres 25 mg tablets

Follow your doctor's instructions for administering this medication exactly. If you are unsure, consult your doctor or pharmacist again.

Essential hypertension

Adults:

Oral. The recommended starting dose is 12.5 mg once a day for the first two days. Then, the recommended dose is 25 mg once a day. If necessary, your doctor may increase the dose you receive (at intervals of at least two weeks) up to 50 mg once a day or in two doses of 25 mg each.

Elderly patients:

Oral. The recommended starting dose is 12.5 mg once a day, which has provided satisfactory control in some patients. If the response is not adequate, your doctor will adjust the dose (at intervals of at least two weeks).

Ischemic heart disease

Adults:

Oral. The recommended starting dose is 12.5 mg twice a day (a total of 25 mg per day) for the first two days. Then, the recommended dose is 25 mg twice a day (a total of 50 mg per day). If necessary, your doctor may increase the dose you receive (at intervals of at least two weeks) up to 50 mg twice a day (a total of 100 mg per day).

Elderly patients:

Oral. The maximum recommended dose for elderly patients is 50 mg administered in divided doses (twice a day).

Treatment of symptomatic congestive heart failure

Adults and elderly patients:

Oral. Your doctor will tell you individually the dose you should take, closely monitoring you during dose adjustment.

If you are using medications for heart conditions (digitalis) or blood pressure control (diuretics and/or ACE inhibitors) and before starting treatment with Coropres, your doctor will adjust the amount of these medications you should take.

In any case, the recommended starting dose for Coropres in the treatment of symptomatic congestive heart failure is 3.125 mg twice a day (a total of 6.25 mg per day) for two weeks. If you tolerate this dose well, it can be increased later (at intervals of at least two weeks) up to 6.25 mg twice a day (a total of 12.5 mg per day). Your doctor may prescribe higher doses of Coropres later (after at least two weeks).

If you weigh less than 85 kg, the maximum recommended dose is 25 mg twice a day (a total of 50 mg per day). If your weight is over 85 kg, the maximum recommended dose is 50 mg twice a day (100 mg per day).

Your doctor will indicate the duration of your treatment with Coropres 25 mg tablets.

As a general rule, regardless of your disease, withdrawal of Coropres 25 mg tablets should be done gradually over a few days, or the dose should be reduced by half every three days.

Use in children and adolescents

Coropres is not recommended for use in children and adolescents under 18 years of age due to insufficient safety and efficacy data.

Guidelines for correct administration

Take the tablets with a sufficient amount of liquid, a glass of water.

If you have congestive heart failure (your heart has lost some of its ability to pump blood and may cause difficulty breathing, weakness, and fluid accumulation), you should take Coropres while eating to avoid dizziness when standing up.

Remember to take your medication.

If you take more Coropres than you should

If you take more Coropres than you should, contact your doctor or go to the nearest hospital immediately. Bring the medication with you.

In case of overdose or accidental ingestion, consult the Toxicological Information Service, Telephone 91 562.04.20.

If you forget to take Coropres

Do not take a double dose to make up for forgotten doses.

If you stop treatment with Coropres

Treatment with Coropres should not be stopped abruptly, especially if you have ischemic heart disease, a condition that causes the heart to not pump blood well. Your doctor will gradually reduce the dose over a few days until you stop taking Coropres completely.

If you have any other questions about the use of this medication, ask your doctor or pharmacist.

4. Possible side effects

Like all medications, this medication can cause side effects, although not everyone will experience them.

Side effects are classified as: very common (may affect more than 1 in 10 people), common (may affect up to 1 in 10 people), uncommon (may affect up to 1 in 100 people), rare (may affect up to 1 in 1,000 people), very rare (may affect up to 1 in 10,000 people), and frequency not known (cannot be estimated from available data).

Infections and infestations

Common: Bronchitis, pneumonia, upper respiratory tract infections, urinary tract infections.

Disorders of the nervous system

Very common: Headache, dizziness, and weakness, which are usually mild and occur mainly at the start of treatment.

Common: Presyncope, syncope (fainting), especially at the beginning of treatment.

Uncommon: Paresthesia (tingling sensation).

Psychiatric disorders

Common: Depressed mood, depression.

Uncommon: Sleep disorders.

Frequency not known: Hallucinations.

Cardiac disorders

Very common: Increased heart failure (the heart has lost some of its ability to pump blood).

Common: Bradycardia (decreased heart rate), fluid overload, increased blood volume in the body.

Uncommon: Atrioventricular (A-V) block (heart problems) and angina pectoris (chest pain).

Frequency not known: Sinus arrest (a condition that makes the heartbeats very slow or stop), especially in elderly patients or patients with other heart rhythm problems.

Vascular disorders

Very common: Low blood pressure.

Common: Postural hypotension (dizziness when standing up or changing body position), peripheral circulation disorders (cold hands and feet), increased symptoms in patients with intermittent claudication (increased pain in the legs when walking) or Raynaud's phenomenon (decreased blood flow to fingers, toes, ears, and nose), hypertension.

Respiratory, thoracic, and mediastinal disorders

Common: Asthma and difficulty breathing in predisposed patients, fluid accumulation in the lungs.

Rare: Nasal congestion.

Gastrointestinal disorders

Common: Gastrointestinal disorders with symptoms such as nausea, diarrhea, abdominal pain, indigestion, vomiting.

Uncommon: Constipation.

Rare: Dry mouth.

Skin and subcutaneous tissue disorders

Uncommon: Skin reactions (e.g., allergic exanthema, dermatitis, urticaria, itching, psoriasis, lichen planus-like skin lesions).

Frequency not known: Hair loss, severe adverse skin reactions (e.g., toxic epidermal necrolysis, Stevens-Johnson syndrome), excessive sweating (hyperhidrosis).

Blood and lymphatic system disorders

Common: Decreased red blood cell count (anemia).

Rare: Decreased platelet count (thrombocytopenia).

Very rare: Decreased white blood cell count (leukopenia).

Hepatobiliary disorders

Very rare: Alterations in serum transaminases (changes in the amount of certain liver enzymes in the blood).

Eye disorders

Common: Decreased tear production (dry eye), eye irritation, vision changes.

Renal and urinary disorders

Common: Acute renal failure (the kidney does not function properly) and disorders of renal function in patients with diffuse vascular disease and/or altered renal function.

Rare: Urination problems.

Frequency not known: Urinary incontinence in women (disappears when the medication is stopped).

Immune system disorders

Very rare: Allergic reactions.

Musculoskeletal and connective tissue disorders

Common: Pain in the extremities.

Reproductive system and breast disorders

Uncommon: Impotence.

Metabolic and nutritional disorders

Common: Worsening of blood sugar control in diabetic patients (hyperglycemia, hypoglycemia), weight gain, increased cholesterol in the blood.

Frequency not known: It is possible that latent diabetes mellitus may manifest or that existing diabetes may worsen.

General disorders and administration site conditions

Very common: Fatigue.

Common: Pain, edema (fluid retention, swelling of the legs, ankles, and feet).

If you consider any of the side effects you are experiencing to be serious or if you notice any side effect not mentioned in this package leaflet, inform your doctor or pharmacist.

Reporting of side effects

If you experience any type of side effect, consult your doctor, pharmacist, or nurse, even if it is a possible side effect not listed in this package leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can contribute to providing more information on the safety of this medication.

5. Storage of Coropres 25 mg tablets

Keep this medicine out of the sight and reach of children.

Store in the original packaging to protect it from light and moisture.

This medicine does not require any special storage temperature.

Do not use this medicine after the expiration date shown on the packaging after CAD. The expiration date is the last day of the month indicated.

Medicines should not be disposed of via wastewater or household waste. Deposit the packaging and any unused medicines at the SIGRE collection point in your pharmacy. If in doubt, ask your pharmacist how to dispose of the packaging and any unused medicines. This will help protect the environment.

6. Package contents and additional information

Composition of Coropres 25 mg tablets

• The active ingredient is carvedilol.
• The other ingredients are lactose, sucrose, povidone, crospovidone, colloidal anhydrous silica, and magnesium stearate.

Appearance of the product and package contents

Coropres 25 mg tablets are round, scored, white to pale beige-yellow in color, with the imprint BM on one side and D5 on the other.

Coropres 25 mg is available in packages of 28 tablets.

Marketing authorization holder and manufacturer

Holder

CHEPLAPHARM Arzneimittel GmbH

Ziegelhof 24

17489 Greifswald

Germany

Manufacturer

CHEPLAPHARM Arzneimittel GmbH

Ziegelhof 23-24

17489 Greifswald

Germany

Local representative

Laboratorios Rubió, S.A.

C/ Industria, 29 - Pol. Ind. Comte de Sert

08755 Castellbisbal (Barcelona)

Spain

Date of the last revision of this prospectus:October 2023

Detailed information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/.